NASDAQ Global Market • Healthcare • Biotechnology • TW • USD
Taiwan Liposome Company, Ltd. (TLC) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
